Topic: remote patient monitoring
With chips designed to run AI programs locally, Google’s Coral venture is partnering with two healthcare startups in different care settings.
Philips is adding LindaCare’s remote monitoring platform for patients with cardiac implants to its IntelliSpace Cardiovascular informatics program.
Biobeat received FDA clearance for its smartwatch patient monitor that tracks blood pressure and other vital signs without a traditional inflated cuff.
The partners will study patient-focused endpoints alongside so-called “hard outcomes" that have traditionally served as endpoints in clinical trials.
Acutus secured $170 million after acquiring a catheter developer and announcing a slew of new partnerships in arrhythmia treatment and monitoring.
Spire Health launched an innovative study to develop digital biomarkers to predict COPD exacerbations and hospitalizations.
Good for up to 90 days, Senseonics’ Eversense CGM comes paired with a mobile app that can notify adults with diabetes if their blood sugar levels go too high or dip too low.
One of the splashier medtech moments of 2018 to come out of an FDA 510(k) decision was the agency’s de novo clearance of the latest Apple Watch and its software allowing on-demand electrocardiograms for the mass-market consumer.
The FDA cleared Current Health’s wearable tracker, designed to be taken home from the hospital after acute care to track a patient’s recovery.
TytoCare is pairing up with big-box electronics retailer Best Buy to put its remote medical exam hardware directly into the hands of consumers.